115 related articles for article (PubMed ID: 26228843)
1. Acute megakaryocytic leukemia: What have we learned.
Hahn AW; Li B; Prouet P; Giri S; Pathak R; Martin MG
Blood Rev; 2016 Jan; 30(1):49-53. PubMed ID: 26228843
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia.
Krause DS; Crispino JD
Clin Cancer Res; 2013 Nov; 19(22):6084-8. PubMed ID: 23963861
[TBL] [Abstract][Full Text] [Related]
3. Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia.
De Marchi F; Araki M; Komatsu N
Expert Rev Hematol; 2019 May; 12(5):285-293. PubMed ID: 30991862
[TBL] [Abstract][Full Text] [Related]
4. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.
Tallman MS; Neuberg D; Bennett JM; Francois CJ; Paietta E; Wiernik PH; Dewald G; Cassileth PA; Oken MM; Rowe JM
Blood; 2000 Oct; 96(7):2405-11. PubMed ID: 11001891
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
6. Histologic and molecular characterizations of megakaryocytic leukemia in mice.
Hao X; Shin MS; Zhou JX; Lee CH; Qi CF; Naghashfar Z; Hartley JW; Fredrickson TN; Ward JM; Morse HC
Leuk Res; 2006 Apr; 30(4):397-406. PubMed ID: 16219351
[TBL] [Abstract][Full Text] [Related]
7. Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.
Xu G; Kanezaki R; Toki T; Watanabe S; Takahashi Y; Terui K; Kitabayashi I; Ito E
Leukemia; 2006 Jun; 20(6):1002-8. PubMed ID: 16628190
[TBL] [Abstract][Full Text] [Related]
8. Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.
Oki Y; Kantarjian HM; Zhou X; Cortes J; Faderl S; Verstovsek S; O'Brien S; Koller C; Beran M; Bekele BN; Pierce S; Thomas D; Ravandi F; Wierda WG; Giles F; Ferrajoli A; Jabbour E; Keating MJ; Bueso-Ramos CE; Estey E; Garcia-Manero G
Blood; 2006 Feb; 107(3):880-4. PubMed ID: 16123215
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of a variant Philadelphia translocation, t(10;22), in de novo acute megakaryoblastic leukemia.
Kaloutsi V; Hadjileontis C; Tsatalas C; Sambani C; Kostopoulos I; Papadimitriou C
Cancer Genet Cytogenet; 2004 Jul; 152(1):52-5. PubMed ID: 15193441
[TBL] [Abstract][Full Text] [Related]
10. [Survival, clinical and laboratory characteristics of de novo and secondary megakaryoblastic leukemia].
Crespo E; López-Karpovitch X; Abraham-Simón J; Lome-Maldonado C; Piedras J
Rev Invest Clin; 2003; 55(5):494-501. PubMed ID: 14968469
[TBL] [Abstract][Full Text] [Related]
11. Relapse of acute megakaryocytic leukemia as hepatic myeloid sarcoma after allogeneic haploidentical hematopoietic stem cell transplantation.
Imamura T; Nitta Y; Miyachi M; Ishida H; Ito M; Hosoi H
Int J Hematol; 2014 Aug; 100(2):109-10. PubMed ID: 24916785
[No Abstract] [Full Text] [Related]
12. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
13. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
14. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
[TBL] [Abstract][Full Text] [Related]
15. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
[TBL] [Abstract][Full Text] [Related]
16. A rare case of GATA1 negative chemoresistant acute megakaryocytic leukemia in an 8-month-old infant with trisomy 21.
Stepensky P; Brooks R; Waldman E; Revel-Vilk S; Izraeli S; Resnick I; Weintraub M
Pediatr Blood Cancer; 2010 Jul; 54(7):1048-9. PubMed ID: 20108342
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia.
Sun J; Wang Z; Luo Y; Tan Y; Allan DS; Huang H
Acta Haematol; 2012; 127(3):143-8. PubMed ID: 22248505
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into Down syndrome-associated leukemia.
Vyas P; Crispino JD
Curr Opin Pediatr; 2007 Feb; 19(1):9-14. PubMed ID: 17224656
[TBL] [Abstract][Full Text] [Related]
19. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
